Artificial Intelligence
CNS Pharmaceuticals and Image Analysis Group Partner to Further the Development of Berubicin
HOUSTON, Sept. 24, 2020 (GLOBE NEWSWIRE) — via NetworkWire — CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) (“CNS” or the “Company”), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the central nervous system, today announced it has selected Image Analysis Group (“IAG”) as the image partner for its upcoming Berubicin clinical trials.
IAG, a leading medical imaging company, will work closely with CNS during the Berubicin clinical trials to provide critical imaging services, its proprietary platform DYNAMIKA and imaging data analysis. IAG has deep expertise in partnering with biotech, and specifically oncology companies, to provide a centralized reading and analysis of patient responses in real time. IAG’s scientific and clinical imaging expertise in the field of GBM will be coupled with IAG’s proprietary AI and quantitative image-based assessments to allow CNS to review efficacy assessments, objective responses, and to thoroughly explore the advanced treatment manifestations. GBM therapies often lead to pseudo-progression, a local tissue reaction resulting from immune cell infiltration, inflammation, tumor necrosis and oedema which are often misinterpreted as tumor growth on traditional MRIs. Pseudo-progression is difficult to distinguish from disease progression using routine clinical MRI assessments. IAG and CNS will be utilizing IAG’s advanced Artificial Intelligence (AI)-driven methodologies that provide reliable early efficacy readouts.
“Adding IAG was a key step in preparation for the recently developed clinical trials in Berubicin,” commented John Climaco, CEO of CNS Pharmaceuticals. “IAG has an exemplary track record of partnering closely with companies in the biotech space to provide critical analysis of both efficacy and patient response, which we believe will be pivotal in advancing our Berubicin clinical trials. Furthermore, this was yet another key milestone achieved in our trial preparations as we continue to take all of the necessary steps to ensure a successful and timely launch of our Phase II trials. We look forward to leveraging IAG’s extensive expertise, as we plan to initiate our Phase II clinical trial of Berubicin in adults early next year.”
“We are excited to partner with CNS and bring our expertise to support the optimal trial design, efficient imaging data management and review. Use of the state-of-the-art and IAG’s AI driven methodologies for imaging data review will allow us to comprehensively explore Berubicin’s efficacy and build significant scientific evidence, while reducing the development costs, timelines and uncertainties,” commented Dr. Olga Kubassova, IAG’s CEO and scientific founder.
“Advanced imaging methods and computer aided image analysis is the key to successfully interpret treatment related changes in GBM and identify responders early,” stated Dr. Diana Dupont-Roettger, Chief Scientific Alliance Officer at IAG. “We are excited to partner with CNS Pharmaceuticals in the development of Berubicin”.
About CNS Pharmaceuticals, Inc.
CNS Pharmaceuticals is developing novel treatments for primary and metastatic cancers of the brain and central nervous system. Its lead drug candidate, Berubicin, is proposed for the treatment of glioblastoma multiforme (GBM), an aggressive and incurable form of brain cancer. CNS holds a worldwide exclusive license to the Berubicin chemical compound and has acquired all data and know-how from Reata Pharmaceuticals, Inc. related to a completed Phase 1 clinical trial with Berubicin in malignant brain tumors, which Reata conducted in 2006. In this trial, 44% of patients experienced a statistically significant improvement in clinical benefit. This 44% disease control rate was based on 11 patients (out of 25 evaluable patients) with stable disease, plus responders. One patient experienced a durable complete response and remains cancer-free as of February 20, 2020. These Phase 1 results represent a limited patient sample size and, while promising, are not a guarantee that similar results will be achieved in subsequent trials. By the end of 2020, CNS expects to commence a Phase 2 clinical trial of Berubicin for the treatment of GBM in the U.S., while a sub-licensee partner undertakes a Phase 2 trial in adults and a first-ever Phase 1 trial in pediatric GBM patients in Poland. Its second drug candidate, WP1244, is a novel DNA binding agent that has shown in preclinical studies that it is 500 times more potent than the chemotherapeutic agent daunorubicin in inhibiting tumor cell proliferation.
About IAG
Image Analysis Group (IAG) is a unique clinical development partner to life sciences companies. IAG broadly leverages its proprietary image analysis methodologies, power of our cloud platform DYNAMIKA, years of experience in AI and Machine Learning as well as bespoke co-development business models to ensure higher probability for promising therapeutics to reach the patients. Our independent Bio-Partnering division fuses risk-sharing business models and agile culture to accelerate novel drug development.
Forward-Looking Statements
Some of the statements in this press release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995, which involve risks and uncertainties. Forward-looking statements in this press release include, without limitation, the ability of the Company to initiate its Phase 2 trial by the end of 2020. These statements relate to future events, future expectations, plans and prospects. Although CNS believes the expectations reflected in such forward-looking statements are reasonable as of the date made, expectations may prove to have been materially different from the results expressed or implied by such forward-looking statements. CNS has attempted to identify forward-looking statements by terminology including ”believes,” ”estimates,” ”anticipates,” ”expects,” ”plans,” ”projects,” ”intends,” ”potential,” ”may,” ”could,” ”might,” ”will,” ”should,” ”approximately” or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements. These statements are only predictions and involve known and unknown risks, uncertainties and other factors, including those discussed in the Company’s SEC filings, including under Item 1A. “Risk Factors” in our most recently filed Form 10-K filed with the Securities and Exchange Commission (“SEC”) and updated from time to time in our Form 10-Q filings and in our other public filings with the SEC. Any forward-looking statements contained in this press release speak only as of its date. CNS undertakes no obligation to update any forward-looking statements contained in this press release to reflect events or circumstances occurring after its date or to reflect the occurrence of unanticipated events.
CONTACTS:
Investor Relations Contact
James Salierno
The Ruth Group
646-536-7028
[email protected]
Media Contact
Kirsten Thomas
The Ruth Group
(508) 280-6592
[email protected]
Wire Service Contact
NetworkWire (NW)
New York, New York
www.NetworkWire.com
212.418.1217 Office
[email protected]
# # #
Artificial Intelligence
Universal Robots and MiR open new robotics hub in Denmark
Global robotics leaders Universal Robots (UR) and Mobile Industrial Robots (MiR), both Teradyne Robotics companies, will share headquarters to increase synergies and accelerate innovation within advanced robotics.
ODENSE, Denmark, May 14, 2024 /PRNewswire/ — Universal Robots, the Danish collaborative robot (cobot) company, and MiR, the Danish manufacturer of AMRs (autonomous mobile robots), today celebrated the Grand Opening of their new 20,000 sqm headquarters in Odense, Denmark.
Partners from UR and MiR’s global ecosystems attended the event, including NVIDIA and Siemens, with whom Teradyne Robotics and its companies have recently announced several collaborations.
“The launch of this new headquarters marks a significant milestone for Teradyne Robotics as we bring together two leading companies in robotics innovation,” says Ujjwal Kumar, Group President of Teradyne Robotics. “We will now have the optimal environment to evolve our technological capabilities, which are already in high demand.”
On the new robotics hub, Jean-Pierre Hathout, President of MiR, said:”Our new headquarters is designed to foster innovation, providing the perfect setting for our teams to develop leading-edge solutions that will revolutionize automation. MiR is committed to being a one-stop-shop for material handling, continuously advancing our technology to meet the evolving needs of our large, global customers. Our recently launched AI-powered MiR1200 Pallet Jack exemplifies this dedication. I’m thrilled to witness the transformative impact of our endeavors and to showcase MiR’s and UR’s offerings to our customers and partners at this state-of-the-art facility.”
Kim Povlsen, President of Universal Robots, added:”Since our foundation, UR has become a platform of choice for thousands of customers and hundreds of ecosystem partners. This beautiful building reflects our strong design philosophy and provides the perfect location for us to continue our mission to deliver automation for anyone, anywhere.”
Transformative power of advanced automationThe opening included a panel discussion featuring Deepu Talla, Vice President of Robotics and Edge Computing of NVIDIA, Rainer Brehm, CEO of Siemens Factory Automation, and Ujjwal Kumar, Group President of Teradyne Robotics. The panelists discussed the use of physical AI across industries, underscoring the transformative power of advanced automation for businesses and workplaces.
Photos from the Grand Opening and a recording of the panel discussion can be viewed on UR and MiR social media channels and will soon be available here.
New HQ factsPictures
About URAbout MiRAbout Teradyne Robotics
Logo – https://mma.prnewswire.com/media/2333087/4701507/Universal_Robots_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/universal-robots-and-mir-open-new-robotics-hub-in-denmark-302144008.html
Artificial Intelligence
Mullen Coughlin LLC Adds DFIR Professional, Chris Ballod, to Incident Response Team
DEVON, Pa., May 14, 2024 /PRNewswire/ — Mullen Coughlin LLC, a leading international data privacy and security law firm, proudly announces the addition of Chris Ballod to the Incident Response team as Senior Partner.
With a legal and professional career spanning over two decades where he held prominent positions within the cyber insurance ecosystem, including most recently as Associate Managing Director for a well-known cybersecurity risk management and digital forensic incident response (DFIR) firm, Chris possesses a deep understanding of the complicated and nuanced data privacy legal landscape and real-life experience in leading forensic investigations into hundreds of various types of data privacy incidents.
“It is my great honor to join the team that made the incident response community what it is today. The attorneys and staff at Mullen Coughlin are some of the best and most experienced in the field, and I am excited for us to face the future of this industry together,” says Chris about joining the Firm.
Chris’s addition reinforces Mullen Coughlin’s commitment to delivering effective and efficient legal services tailored to each organization’s unique needs – prior, during, and after a data privacy and security incident. With a proven record of success for organizations around the globe, Chris’s knowledge and experience further strengthens Mullen Coughlin’s ability to provide unmatched cybersecurity and data privacy legal counsel to organizations of all sizes and across all industry sectors.
“The addition of our friend, and now colleague, is another chapter in the Firm’s dedication to one theme – One Firm, One Focus: Cyber,” says Mullen Coughlin CEO John F. Mullen . “I’ve worked with Chris for many years, both at previous law firms and as a business partner, and know that he will make an immediate impact here and for our clients and cyber insurance partners.”
Mullen Coughlin Managing Member, Jennifer A. Coughlin , adds, “Chris is recognized by all in the market as having unmatched legal and forensic investigatory experience, and we are excited for him to utilize this experience to further solidify the Firm’s established reputation as the go-to law firm for data privacy and incident response legal counsel, consistently delivering on the needs of the cyber insurance industry.”
Mullen Coughlin has managed over 25,000 data privacy and security incidents on behalf of organizations of all sizes, across all industry sectors and from all geographic locations. Mullen Coughlin has over 120 experienced attorneys solely dedicated to providing bespoke counsel relating to pre-incident Advisory Compliance services and solutions; data privacy and security incident response ; regulatory investigation ; and security and privacy litigation defense. For more information, please visit www.mullen.law .
View original content:https://www.prnewswire.co.uk/news-releases/mullen-coughlin-llc-adds-dfir-professional-chris-ballod-to-incident-response-team-302144257.html
Artificial Intelligence
QorusDocs’ New AI-Powered Solution, QPilot, Transforms RFP and Proposal Development
Specialized, private and secure AI features return immediate ROI to professional services firms
BELLEVUE, Wash., May 14, 2024 /PRNewswire/ — QorusDocs, an AI-powered proposal management software provider, today announced QorusDocs’ QPilot, a new secure and private AI service that exponentially simplifies the task of crafting pitches, proposals and RFP responses for professional services firms.
Core Features Ensure Security, Privacy and Immediate ROI
QorusDocs’ QPilot AI service, built on the Microsoft Azure OpenAI Service, offers unparalleled security and privacy for firm’s private content libraries, past RFPs, proposals and internal content.
QPilot gives users access to pre-built and customizable prompts that make it indispensable for professional services teams, who frequently work with biographies, credentials and project records in volume, and need to craft compelling written and visual presentations.
By allowing secure, targeted access to a firm’s sensitive documents and content, QPilot produces advantages for proposal creators not found in other generative AI software. This allows business development teams to focus on high-value client engagement, instead of mundane tasks.
QorusDocs AI Assistant, QPilot, brings the following benefits to users:
Accelerates research, personalization, and creation of tailored content Streamlines workflows directed towards high-value, winnable bids Integrates seamlessly with Microsoft 365 apps for ease of use “We developed QorusDocs’ QPilot as part of our continued focus on expanding our AI footprint to help service-based businesses revolutionize their proposal process,” said Ray Meiring, CEO and co-founder of QorusDocs. “During our testing phase, we verified common use cases for professional services teams and gathered feedback to ensure the first version of QorusDocs’ AI Assistant, QPilot, returns immediate time to value to our customers.”
The Verdict is in: Customers Love QorusDocs’ QPilot
“QorusDocs’ AI platform has brought significant efficiency gains to TRC’s proposal process”, explained Dr. Stephen R. Galati, Vice President, Strategic Proposals, TRC Companies, Inc. “Before QorusDocs’ QPilot, we would spend time searching for information and refining it into proposals. Now, with QorusDocs’ QPilot, we’ve experienced notable productivity gains, specifically planning, resource, writing, collaboration and time efficiencies, allowing our team to focus on the technical content rather than stylistic elements. QorusDocs’ seamless integration with Microsoft 365 apps provides fast access to information and gives us a strong level of confidence in data security.”
Customer and Analyst Acclaim
Known for its compelling platform, QorusDocs has received top honors by SoftwareReviews in its research analysis. In April 2024, QorusDocs was ranked #1 in product performance and Champion in Emotional Sentiment in the Proposal Management category.
In line with its existing platform, QorusDocs’ QPilot has already earned high praise from customers and analysts who have used the preview version, with 100% of users reporting productivity increases.
“Generative AI is creating exponential opportunities across the professional services industry, shared Robert Garmaise, Vice President of Artificial Intelligence Research at Info-Tech Research Group. QorusDocs is both a leader and chief catalyst in this transformation, as they streamline critical sales deliverables such as pitches, proposals and RFP responses. QorusDocs is a no-brainer for any professional services partner looking to maximize their reach while minimizing non-billable time.”
QorusDocs’ AI Assistant, QPilot will be available on June 5, 2024.
To see how QorusDocs’ QPilot can transform your proposal processes, visit QorusDocs AI Assistant | QPilot.
ABOUT QORUSDOCS QorusDocs, based in Bellevue, Wash., is a leader in AI-powered proposal management and RFP response software that automates the creation of personalized pitches, presentations, proposals, and RFP responses. QorusDocs empowers business development, sales, marketing, and proposal teams to collaborate seamlessly, optimizing billable hours and increasing client wins. The company supports enterprise revenue teams from companies like WSP, CDW, DLA Piper, Baker McKenzie, Insight and more.
Logo – https://mma.prnewswire.com/media/1683975/Logo_Full_QD_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/qorusdocs-new-ai-powered-solution-qpilot-transforms-rfp-and-proposal-development-302144247.html
-
Artificial Intelligence6 days ago
Körber Pharma and Siemens Take the Lead in ABI Research’s MES Software for Pharmaceutical, Biotechnology, and Cell & Gene Manufacturing Competitive Ranking
-
Artificial Intelligence6 days ago
New Momentum in Pharma Automation: ArisGlobal’s 2024 Industry Survey Report Highlights Surge in AI-Powered Safety & Regulatory Processes
-
Uncategorized6 days ago
Smart Waste Management Market to Reach $8.3 billion by 2032 at 15.6% CAGR: Allied Market Research
-
Artificial Intelligence6 days ago
Ness Digital Engineering Acquires Intricity – a New York based company specializing in data strategy, governance, modernization, and monetization
-
Artificial Intelligence4 days ago
Sanad Announces Strategic Sale Transaction with CFM Materials, Further Fostering Aviation Industry Collaborations
-
Artificial Intelligence4 days ago
Northern Data Group’s Peak Mining announces new partnership for 28MW of mining, powered by 100% renewable energy
-
Artificial Intelligence4 days ago
Identity Threat Detection and Response (ITDR) Market worth $35.6 billion by 2029- Exclusive Report by MarketsandMarkets™
-
Artificial Intelligence4 days ago
Linnovate Partners Announces Close of USD 40 Million Funding Commitment Led by SeaTown